Spirogen

Spirogen

Verified
Clinical stage biotechnology company specialising in novel, sequence-selective, DNA minor groove-binding molecule

Launch date
Employees
Firm valuation
$105—150m (Dealroom.co estimates Oct 2009.)
London England (HQ)
Deals in current and previous year:

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues-1m-----

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
N/A£1mSeed
$15mGrowth Equity VC
N/AAcquisition
Total Funding$16.3m

Recent News about Spirogen

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Spirogen

Edit